Company Filing History:
Years Active: 2011
Title: Marian Mosior: Innovator in Cardiovascular Treatment
Introduction
Marian Mosior is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of cardiovascular treatment through her innovative research and patent work. Her dedication to improving health outcomes is evident in her groundbreaking discoveries.
Latest Patents
Marian Mosior holds a patent related to the administration of sPLAinhibitors. This invention has been found to decrease cholesterol levels, atherosclerotic plaque formation, and aortic aneurysm in mice. Additionally, it has shown to decrease cholesterol and triglyceride levels in humans. Notably, the administration of sPLAinhibitors was effective even when given only once per day. The patent outlines methods for treating dyslipidemia, cardiovascular disease (CVD), and conditions associated with CVD, such as atherosclerosis and metabolic syndrome. Furthermore, the combination of sPLAinhibitors with other compounds, like statins, resulted in greater decreases in LDL and LDL particle levels, demonstrating a synergistic effect.
Career Highlights
Marian Mosior is currently associated with Anthera Pharmaceuticals, Inc., where she continues her research and development efforts. Her work has been instrumental in advancing treatment options for patients suffering from cardiovascular conditions.
Collaborations
Throughout her career, Marian has collaborated with notable colleagues, including Joaquim Trias and Colin Hislop. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Marian Mosior's contributions to cardiovascular treatment through her patent on sPLAinhibitors highlight her role as a leading inventor in the field. Her work not only advances medical science but also offers hope for improved health outcomes for patients with cardiovascular diseases.